LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
TCRXCIK 0001783328

TScan Therapeutics, Inc.

14 transactions by 11 insiders, from January 20, 2026 to October 1, 2026.

Transactions
1411 insiders
Bought · P
Nonenobody bought on the open market
Sold · S
Nonenobody sold on the open market
Net
+$0net buying

Officers and directors

People inside the company. What they do with their own shares is the reason this data exists.

InsiderTradesPlannedBoughtSold
BAKER BROS. ADVISORS LPDir2———
Gavin MacBeathCEO2———
Zoran ZdraveskiOfficer2———
Garry A. NicholsonDir1———
Barbara KlenckeDir1———
Keith WoodsDir1———
Chrystal LouisCMO1———
Gabriela GruiaDir1———
Leiden DworakOfficer1———
Jason AmelloCFO1———
Katina DortonDir1———

All transactions

14 in total, newest filings first.

InsiderDateCodeSharesPriceValue
Gavin MacBeathCEOOct 1A1,000,000$0.00—
Zoran ZdraveskiOfficerOct 1A300,000$0.00—
Keith WoodsDirDERIVMay 20A67,000$0.00—?
Garry A. NicholsonDirDERIVMay 20A67,000$0.00—?
Barbara KlenckeDirDERIVMay 20A67,000$0.00—?
Gabriela GruiaDirDERIVMay 20A67,000$0.00—?
Katina DortonDirDERIVMay 20A67,000$0.00—?
BAKER BROS. ADVISORS LPDirDERIVJOINTMay 20A67,000$0.00—?
BAKER BROS. ADVISORS LPDirDERIVJOINTMay 20A67,000$0.00—?
Zoran ZdraveskiOfficerDERIVJan 20A350,000$0.00—?
Gavin MacBeathCEODERIVJan 20A1,165,000$0.00—?
Chrystal LouisCMODERIVJan 20A420,000$0.00—?
Leiden DworakOfficerDERIVJan 20A100,000$0.00—?
Jason AmelloCFODERIVJan 20A350,000$0.00—?